Lithobid

Lithobid is a brand name of lithium, approved by the FDA in the following formulation(s):

LITHOBID (lithium carbonate - tablet, extended release; oral)

• 
  Manufacturer: NOVEN THERAP
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 300MG ^[RLD][AB]

Has a generic version of Lithobid been approved?

Yes. The following products are equivalent to Lithobid:

lithium carbonate tablet, extended release; oral

• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: December 27, 2010
  
  Strength(s): 300MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: October 28, 2004
  
  Strength(s): 300MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lithobid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Lithobid.

See also...

• Lithobid Controlled-Release and Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Lithobid Consumer Information (Cerner Multum)
• Lithobid Advanced Consumer Information (Micromedex)
• Lithium Consumer Information (Drugs.com)
• Lithium Consumer Information (Wolters Kluwer)
• Lithium Controlled-Release and Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Lithium Syrup Consumer Information (Wolters Kluwer)
• Lithium Consumer Information (Cerner Multum)
• Lithium Advanced Consumer Information (Micromedex)
• Lithium Salts AHFS DI Monographs (ASHP)